The industry is now entering the next era by embedding AI directly into the software field teams’ use every day. The step ...
Health equity is an ambitious goal, but the drive to deliver life-changing innovation to all eligible patients is ...
What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der ...
Follow-up results from the phase 3 EMBER-3 study showed that, as a monotherapy, Inluriyo demonstrated a 38% reduction in the ...
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to ...
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to ...
Galderma’s Nemluvio (nemolizumab) has shown rapid relief of itch, as well as improvement in sleep, in patients with atopic ...
Building a trusted data foundation The starting line for any successful AI journey is data readiness and quality. Before ...
At Avalere Health, we have identified six crucial elements of a successful launch, driven by insight, integrated working, ...
When influence outpaces expertise However, the rise of health content on social media has also fuelled the parallel problem ...
Organisations that allow AI to operate responsibly at scale can achieve speed and quality gains while remaining compliant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results